A. G. Pockley

The localization of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing HER2

G. Ball, I. Ellis, R. Rees, 2017, Oncotarget.

Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment

Chris J. Tinsley, S. Cuzzubbo, J. Pearson, 2020, Frontiers in Immunology.

Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

J. Paul Robinson, Jonathan A. Rebhahn, Kylie M. Quinn, 2019, European journal of immunology.

HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer

G. Ball, I. Ellis, R. Rees, 2014, British Journal of Cancer.

Influence of opioids on immune function in patients with cancer pain: from bench to bedside

A. Pockley, J. Boland, A. G. Pockley, 2018, British journal of pharmacology.

Crosstalk Between NK Cell Receptors and Tumor Membrane Hsp70‐Derived Peptide: A Combined Computational and Experimental Study

Ali Bashiri Dezfouli, V. Zarezade, Fatemeh Khademi moghadam, 2024, Advanced science.

Identifying the Presence of Prostate Cancer in Individuals with PSA Levels <20 ng ml−1 Using Computational Data Extraction Analysis of High Dimensional Peripheral Blood Flow Cytometric Phenotyping Data

G. Foulds, A. Pockley, G. Cosma, 2017, Front. Immunol..

A preliminary evaluation of the effects of opioids on innate and adaptive human in vitro immune function

G. Foulds, A. G. Pockley, Jason W Boland, 2013, BMJ Supportive & Palliative Care.